These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 8484481

  • 41. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
    Li H, Jiang P, Wang L.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
    [Abstract] [Full Text] [Related]

  • 42. Cellular sources of transforming growth factor-alpha in human oral cancer.
    Todd R, Chou MY, Matossian K, Gallagher GT, Donoff RB, Wong DT.
    J Dent Res; 1991 May; 70(5):917-23. PubMed ID: 2022775
    [Abstract] [Full Text] [Related]

  • 43. [New immunobiologic trends concerning etiopathogenicity of cholesteatoma].
    Bujía J.
    An Otorrinolaringol Ibero Am; 1994 May; 21(2):199-206. PubMed ID: 7516122
    [Abstract] [Full Text] [Related]

  • 44. Epidermal Langerhans cells in cholesteatoma.
    Gantz BJ.
    Ann Otol Rhinol Laryngol; 1984 May; 93(2 Pt 1):150-6. PubMed ID: 6712088
    [Abstract] [Full Text] [Related]

  • 45. [Angiogenesis in cholesteatoma of the middle ear].
    Bujía J, Holly A, Stammberger M, Sudhoff H.
    Acta Otorrinolaringol Esp; 1996 May; 47(3):187-92. PubMed ID: 8924281
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues.
    Cohen DW, Simak R, Fair WR, Melamed J, Scher HI, Cordon-Cardo C.
    J Urol; 1994 Dec; 152(6 Pt 1):2120-4. PubMed ID: 7525998
    [Abstract] [Full Text] [Related]

  • 51. Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway.
    Mórocz IA, Schmitter D, Lauber B, Stahel RA.
    Br J Cancer; 1994 Nov; 70(5):850-6. PubMed ID: 7947089
    [Abstract] [Full Text] [Related]

  • 52. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.
    Nilsson O, Wängberg B, Kölby L, Schultz GS, Ahlman H.
    Int J Cancer; 1995 Mar 03; 60(5):645-51. PubMed ID: 7860139
    [Abstract] [Full Text] [Related]

  • 53. Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast carcinoma. An immunohistologic study.
    Castellani R, Visscher DW, Wykes S, Sarkar FH, Crissman JD.
    Cancer; 1994 Jan 15; 73(2):344-9. PubMed ID: 8293398
    [Abstract] [Full Text] [Related]

  • 54. Restricted expression of Ki-67 in cholesteatoma epithelium.
    Mayot D, Béné MC, Perrin C, Faure GC.
    Arch Otolaryngol Head Neck Surg; 1993 Jun 15; 119(6):656-8. PubMed ID: 7684591
    [Abstract] [Full Text] [Related]

  • 55. Alteration of epidermal differentiation in middle ear cholesteatoma.
    Stammberger M, Bujía J, Kastenbauer E.
    Am J Otol; 1995 Jul 15; 16(4):527-31. PubMed ID: 8588655
    [Abstract] [Full Text] [Related]

  • 56. High levels of fibronectin in the stroma of aural cholesteatoma.
    Schilling V, Holly A, Bujía J, Schulz P, Kastenbauer E.
    Am J Otolaryngol; 1995 Jul 15; 16(4):232-5. PubMed ID: 7573742
    [Abstract] [Full Text] [Related]

  • 57. Role of transforming growth factor-alpha (TGF-alpha) in basal and hormone-stimulated growth by estradiol, prolactin and progesterone in human and rat mammary tumor cells: studies using TGF-alpha and EGF receptor antibodies.
    Ahmed SR, Badger B, Wright C, Manni A.
    J Steroid Biochem Mol Biol; 1991 Jun 15; 38(6):687-93. PubMed ID: 2064983
    [Abstract] [Full Text] [Related]

  • 58. Immunoreactivity of antibodies to epidermal growth factor, transforming growth factors alpha and beta, and epidermal growth factor receptor in the premenopausal ovary.
    Scurry JP, Hamand KA, Astley SB, Leake RE, Wells M.
    Pathology; 1994 Apr 15; 26(2):130-3. PubMed ID: 8090583
    [Abstract] [Full Text] [Related]

  • 59. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
    Holly A, Sittinger M, Bujia J.
    Eur Arch Otorhinolaryngol; 1995 Apr 15; 252(6):366-9. PubMed ID: 8679157
    [Abstract] [Full Text] [Related]

  • 60. Integrin expression in middle ear cholesteatoma.
    Dallari S, Cavani A, Bergamini G, Girolomoni G.
    Acta Otolaryngol; 1994 Mar 15; 114(2):188-92. PubMed ID: 7515549
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.